Skip to main content

Articles

Original Research, Clinical
Provider and Payer Perspectives on the Impact of the COVID-19 Pandemic on Patients With Opioid Use Disorder: Multi-Stakeholder In-Depth Interviews
Maher Abdel-Sattar, PharmD, MS, FAMCP; Seth Cook, PharmD, MS; Ann Wheeler, PharmD; William Mullen, PA-C, MPH; Brett Alyson Maiese, PhD, MHS; Christian Heidbreder, PhD, MA; William Santoro, MD, FASAM, DABAM
Read More
Breast Cancer
Radiation May Be Safely Omitted in Favorable-Risk Breast Cancer Patients Aged 50 to 69 Years
Read More
Online Only
Business, Original Research
A Retrospective Trend Analysis of Utilization, Spending, and Prices for Generic Statins in the US Medicaid Population, 1991-2022
Yiyu Chen, MS; Patricia R. Wigle, PharmD, PhD; Orson Austin, MD; Jeff Jianfei Guo, BPharm, PhD
Read More
Foreword
Welcome to another installment of the 2023 PAYERS’ GUIDE TO FDA UPDATES: Year-End Approvals, Upcoming Decisions
Read More
Expert Perspective
Prescription Drug Provisions in the Inflation Reduction Act of 2022: A Payer Perspective
Read More
In-Depth Drug Profile
FDA-Approved Nirogacestat Demonstrates Improved Patient Outcomes in Desmoid Tumor Management
Jerm Day-Storms, PhD, MWC
Read More
In-Depth Drug Profile
Exa-cel and Lovo-cel Provide Potential Functional Cure for Patients with SCD or TDT
Jerm Day-Storms, PhD, MWC
Read More
FDA Pipeline
Upcoming FDA Actions, January Through March 2024
Read More
FDA Approvals
Directory of FDA Approvals, August Through December 2023
Read More
FDA Approvals
Iwilfin FDA Approved for Adults and Pediatric Patients with High-Risk Neuroblastoma
Read More
Page 1 of 246
Results 1 - 10 of 2457